Inhibition of endothelial cell adhesion molecule expression improves colonic hyperalgaesia

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Background:

• Leukocyte-endothelial cell interactions are crucial for leukocyte infiltration and intestinal inflammation.
• GI270384X inhibits intercellular adhesion molecule 1 (ICAM-1) and E-selectin expression, reducing leukocyte adhesion and improving experimental colitis.
• The study investigated GI270384X's potential in treating visceral hyperalgesia.

Purpose of the Study:

• To evaluate the efficacy of GI270384X in various visceral hyperalgesia models in rats.
• To determine if inhibiting leukocyte-endothelial cell interactions impacts visceral pain perception.

Main Methods:

• Visceromotor responses to colorectal distension (CRD) were measured in rats subjected to inflammatory (zymosan, TNBS) or stress models, or in a high-anxiety Wistar-Kyoto (WKY) rat model.
• Rats received oral GI270384X or vehicle before or after stimulus administration.
• Minimum efficacious doses (MED) were determined for different models.

Main Results:

• GI270384X significantly attenuated enhanced visceromotor responses in inflammatory (TNBS, zymosan) and high-anxiety WKY rat models.
• The drug was most potent in acute inflammatory models (MED 0.3-1 mg/kg).
• GI270384X showed reduced potency in chronic/postinflammatory models (MED 10-30 mg/kg) and did not affect stress-induced hypersensitivity.

Conclusions:

• Inhibition of leukocyte-endothelial cell interactions via GI270384X is beneficial for visceral hyperalgesia associated with inflammation and chronic anxiety.
• GI270384X is less effective against stress-associated visceral hyperalgesia.
• This study highlights a novel therapeutic approach for specific types of visceral pain.